Back to Search
Start Over
Optimization of X-linked chronic granulomatous disease modelization by using patient-specific induced pluripotent stem cells
- Source :
- Experimental Hematology, Experimental Hematology, 2013, 41 (8), pp.S28. ⟨10.1016/j.exphem.2013.05.112⟩, Experimental Hematology, Elsevier, 2013, 41 (8), pp.S28. ⟨10.1016/j.exphem.2013.05.112⟩
- Publication Year :
- 2013
- Publisher :
- HAL CCSD, 2013.
-
Abstract
- International audience; Induced pluripotent stem cells (iPSCs) are reprogrammed somatic cells with embryonic stem cell (ESC)-like characteristics generated by the introduction of combinations of specific transcription factors. Patient-specific iPSCs can be used to recapitulate disease-specific phenotypes for the screening of new therapies. Chronic granulomatous disease (CGD), a rare inherited immunodeficiency, is characterized by recurrent and severe infections in childhood. The most frequent form is the X-linked CGD (X-CGD) due to mutations in CYBB leading to the absence of Nox2 of the phagocytic NADPH oxidase complex, responsible for the production of microbicidal reactive oxygen species.
- Subjects :
- 0303 health sciences
Cancer Research
Pathology
medicine.medical_specialty
business.industry
[SDV]Life Sciences [q-bio]
Cell Biology
Hematology
Patient specific
medicine.disease
3. Good health
03 medical and health sciences
0302 clinical medicine
Chronic granulomatous disease
030220 oncology & carcinogenesis
Genetics
medicine
Induced pluripotent stem cell
business
Molecular Biology
030304 developmental biology
Subjects
Details
- Language :
- English
- ISSN :
- 0301472X
- Database :
- OpenAIRE
- Journal :
- Experimental Hematology, Experimental Hematology, 2013, 41 (8), pp.S28. ⟨10.1016/j.exphem.2013.05.112⟩, Experimental Hematology, Elsevier, 2013, 41 (8), pp.S28. ⟨10.1016/j.exphem.2013.05.112⟩
- Accession number :
- edsair.doi.dedup.....d1b764de374abf3afbff791e791cf778
- Full Text :
- https://doi.org/10.1016/j.exphem.2013.05.112⟩